Facebook Tracking Image

National Comprehensive Cancer Network

Interactive CME

Educational Events & Programs

NCCN Policy Summit:
The State of Cancer Care in America: The Impact of State Policy on Access to High-Quality Cancer Care


NCCN POLICY SUMMIT DATE > Thursday, June 27, 2019 > Register Now!

NCCN POLICY SUMMIT LOCATION > The National Press Club • Washington, DC



Register Now! The NCCN will host a Policy Summit: The State of Cancer Care in America: The Impact of State Policy on Access to High-Quality Cancer Care on June 27, 2019 in Washington, DC.

The summit will explore the increasing role of state authorities in health policy decision-making and implications for patient access to high quality cancer care. Major themes of the summit will include the current state regulatory environment governing insurance marketplaces and benefit design, variability across federal and state-level health care coverage landscapes, and best practices for policy makers, providers, and patient advocates to protect patient access to high quality cancer care within shifting legislative and regulatory environments.

Please check back often for additional updates regarding the summit. If you have any meeting content or agenda questions, please contact Alyssa Schatz, Director, Policy and Advocacy, U.S. and Global Development. For any media questions, please contact Rachel Darwin, Public Relations Manager.


8:30 – 9:30 AM

Breakfast and Registration


9:30 – 9:40 AM

Welcome and Introductions


9:40 – 10:30 AM

Federal Waivers and the Evolving Role of States
in Healthcare Policy


10:30 – 10:40 AM



10:40 AM – 12:00 PM

Panel Discussion:
Shifting Regulatory Authority from the Federal Government to
States and the Implications for Patient Access
to High-Quality Cancer Care


12:00 – 12:50 PM



12:50 AM – 1:30 PM

The Evolving Role of States in Ensuring Access
to High-Quality Cancer Care


1:35 – 2:55 PM

Panel Discussion:
Trends in Cancer Care Policy at the State Level


2:55 - 3:00 PM

Wrap-up and Conclusions


*Subject to change.


Supported by Abbvie; Supported by Adaptive Biotechnologies; Supported by AmerisourceBergen; Supported by Astellas; Supported by AstraZeneca through its NCCN Corporate Council Membership; Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.; Sponsored by Dendreon Pharmaceuticals LLC; Supported by Eisai Inc.; Supported by EMD Serono; Supported by Ferring Pharmaceuticals; Supported by Foundation Medicine, Inc.; Supported by Halozyme; Supported by HELSINN; Supported by Heron; Supported by Incyte Corporation; Supported by Janssen Oncology; Pharmaceutical Companies of Johnson & Johnson; Supported by Kite, a Gilead Company; Supported by an independent educational grant from Merck & Co., Inc.;  This activity was made possible by Pharmacyclics, an AbbVie Company; Supported by Regeneron Pharmaceuticals Inc; Supported by Tesaro; Supported by Verastem Oncology.

As of February 20, 2019.

Access the Library of White Papers!

NCCN offers a broad library of white papers from previous summits that may be pertinent to your organization.

View Supporter Opportunities.

NCCN offers organizations various supporter opportunities.